The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

在全球经济复苏的不确定性中，抗疫概念股成为了股市中的一股强势力量。近日，美股市场上耳熟能详的抗疫概念股再次引发投资者的关注，尤其是Moderna公司，其股价在当地时间1月23日暴涨10.1%。这种异动不仅吸引了市场的眼球，也促使我们思考背后更深层次的原因。

Investing.com -- Moderna Inc (NASDAQ: MRNA )的股价周二午盘上涨5.4%，因RFK Jr.澄清他并非反疫苗或反行业的立场，似乎提振了投资者信心。这家生物技术公司的股价走势伴随着其他行业参与者如Novavax, Inc. (NASDAQ: NVAX )、BioNTech SE (NASDAQ: BNTX )和Pfizer Inc. (NYSE: PFE ...

Bavarian Nordic and Moderna. Pfizer's complaint is that GSK and a Quebec, Canada-based subsidiary ID Biomedical are causing "commercial uncertainty" for its own RSV vaccine programme with the ...

At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...

Leerink Partners analyst Mani Foroohar has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Invest with ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

Vaccine makers faced a difficult year in 2024, as demand for both COVID and RSV shots ebbed compared to 2023. According to Jefferies analyst Michael Yee, COVID vaccinations involving Moderna, Pfizer ...